Evidence map›Paper›PMID 41551076›Full record

ArticleInfectious diseases & clinical microbiology2025

Fatal Breakthrough Invasive Fungal Infection due to

Işıl Ezel Taşkın Karaça, Seval Özen, Turan Bayhan, Avni Merter Keçeli, Ahmet Erhan Kişi, Aysun Yahşi, Fatma Burçin Kurtipek, Agah Yeniçeri, Aslınur Özkaya Parlakay, Gülsüm İclal Bayhan

Abstract readCase Reports
In one paragraph

Article in Infectious diseases & clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Işıl Ezel Taşkın KaraçaDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0002-8410-1364
Seval ÖzenDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-8342-3786
Turan BayhanDepartment of Pediatric Hematology/Oncology, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-5793-5606
Avni Merter KeçeliDepartment of Radiology, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0002-9412-6733
Ahmet Erhan KişiDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0009-0007-0013-4374
Aysun YahşiDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0002-7245-2028
Fatma Burçin KurtipekDepartment of Pediatric Hematology/Oncology, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-9382-3927
Agah YeniçeriDepartment of Ear Nose and Throat, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0002-5024-4009
Aslınur Özkaya ParlakayDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-5691-2461
Gülsüm İclal BayhanDepartment of Pediatric Infections and Diseases, University of Health Science Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0002-1423-4348

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine deaminase 2 (ADA-2) deficiency is a rare autoinflammatory and immunodeficiency disorder that predisposes affected individuals to severe infections. We report the case of a 13-year-old boy with a homozygous CECR1 (c.11104 del) mutation who developed fatal breakthrough invasive aspergillosis caused by

Indexed as

Adenosine deaminase deficiencyAspergillus flavusbreakthrough infectionfatalfungal

Identifiers

PMID41551076
PMCPMC12805476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.